FDA approves Boostrix to prevent three diseases in older people

Share this article:
FDA approves Boostrix to prevent three diseases in older people
FDA approves Boostrix to prevent three diseases in older people

The Food and Drug Administration has approved the Boostrix vaccine for the treatment of  tetanus, diphtheria and pertussis (whooping cough) in people ages 65 and older. Boostrix is the first vaccine approved to prevent all three diseases in older people.

“Pertussis is a highly contagious disease and outbreaks have occurred among the elderly in nursing homes and hospitals,” said Karen Midthun, M.D., director of FDA's Center for Biologics Evaluation and Research


Share this article:

More in Products

Aviv REIT offers public stock

Aviv REIT announced the public offering of 8 million shares of common stock at a public offering price of $24.10 per share.

NCAL unveils 2014 Assisted Living Week logo

NCAL unveils 2014 Assisted Living Week logo

The National Center for Assisted Living is encouraging communities to use the 2014 "The Magic of Music" logo to celebrate National Assisted Living Week.

New healthcare educational catalog available

New healthcare educational catalog available

Nasco has released its 2014-2015 Health Care Educational Materials catalog, which focuses on training with versatile medical procedure simulators.